Fuyi Song (富伊松)富伊松
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 上海中华药业有限公司Chinese legal name: 上海中华药业有限公司
主要成分Active Ingredients
- 地塞米松Disai Misong
- 薄荷脑Bohe Nao
- 樟脑Zhang Nao
- 桉油等Anyou Deng
药物知识说明
地塞米松是一种在国家药监局注册认定的药品。该药品含有地塞米松、桉油等、樟脑-ac7df219等成分。
该药品关联的活性成分包括：地塞米松Disai Misong、桉油等Anyou Deng、樟脑Zhang Nao、薄荷脑Bohe Nao。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：上海中华药业有限公司Chinese legal name: 上海中华药业有限公司。
您可以探索含有相同成分的其他药品：地塞米松-a4207ab1成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 富伊松) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 地塞米松Disai Misong, 桉油等Anyou Deng, 樟脑Zhang Nao, 薄荷脑Bohe Nao.
Manufacturers recorded for this product: 上海中华药业有限公司Chinese legal name: 上海中华药业有限公司.
Explore other medicines containing the same ingredient: 地塞米松 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 富伊松Recorded Chinese name: 富伊松
- 剂型Dosage form: 乳膏剂Cream
- 规格Specification: 0.02%,本品为复方制剂，每克含醋酸地塞米松、薄荷脑、樟脑、桉油等Recorded Chinese composition: 0.02%,本品为复方制剂，每克含醋酸地塞米松、薄荷脑、樟脑、桉油等
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 上海中华药业有限公司Chinese legal name: 上海中华药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10950181
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10950181
Manufacturer
Chinese legal name: 上海中华药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10950181
生产企业
上海中华药业有限公司(国产)
适应症
适用于神经性皮炎、慢性湿疹、虫咬性皮炎及瘙痒性皮肤病的局部治疗。
用法用量
外用，涂于患处。每日2～3次。或遵医嘱。
不良反应
长期大量使用可继发细菌、真菌感染，局部可发生痤疮、酒渣样皮炎、皮肤 萎缩及毛细血管扩张，并可有瘙痒、色素沉着、颜面红斑、创伤愈合障碍等反应。
禁忌
真菌性或病毒性皮肤病禁用，对本药及其他皮质类固醇过敏者禁用。
注意事项
1.孕妇、哺乳期妇女及小儿慎用。 2.破损皮肤及粘膜部位不宜使用。 3.避免大面积应用 4.并发细菌及病毒感染时，应与抗菌药物合用。
贮藏
密闭，在凉处保存
规格
0.02%,本品为复方制剂，每克含醋酸地塞米松、薄荷脑、樟脑、桉油等
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.